Poor Control of Sarcoidosis-Related Panuveitis with an Antibody to IL-23

Akshay S. Thomas; James T. Rosenbaum

doi:10.1080/09273948.2019.1569245

Poor Control of Sarcoidosis-Related Panuveitis with an Antibody to IL-23

Akshay S. Thomas, James T. Rosenbaum

Ophthalmology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	491-493
Number of pages	3
Journal	Ocular Immunology and Inflammation
Volume	28
Issue number	3
DOIs	https://doi.org/10.1080/09273948.2019.1569245
State	Published - Apr 2 2020

ASJC Scopus subject areas

Immunology and Allergy
Ophthalmology

Access to Document

10.1080/09273948.2019.1569245

Cite this

@article{7fa1b1400b9f4fb9adcaa76e104383d7,

title = "Poor Control of Sarcoidosis-Related Panuveitis with an Antibody to IL-23",

author = "Thomas, {Akshay S.} and Rosenbaum, {James T.}",

note = "Funding Information: AST and JTR are supported by an unrestricted institutional grant from Research to Prevent Blindness (New York, NY) and core grant P30 EY010572 from the National Institute of Health (Bethesda, MD). This work was supported NIH grant EY026572 and funds from the William and Mary Bauman Foundation and the Stan and Madelle Rosenfeld Family Trust. JTR is a consultant for Abbvie, UCB, Gilead, Roche, Janssen, Santen, Novartis. He receives research support from Pfizer. He receives royalties from UpToDate.",

year = "2020",

month = apr,

day = "2",

doi = "10.1080/09273948.2019.1569245",

language = "English (US)",

volume = "28",

pages = "491--493",

journal = "Ocular Immunology and Inflammation",

issn = "0927-3948",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Poor Control of Sarcoidosis-Related Panuveitis with an Antibody to IL-23

AU - Thomas, Akshay S.

AU - Rosenbaum, James T.

N1 - Funding Information: AST and JTR are supported by an unrestricted institutional grant from Research to Prevent Blindness (New York, NY) and core grant P30 EY010572 from the National Institute of Health (Bethesda, MD). This work was supported NIH grant EY026572 and funds from the William and Mary Bauman Foundation and the Stan and Madelle Rosenfeld Family Trust. JTR is a consultant for Abbvie, UCB, Gilead, Roche, Janssen, Santen, Novartis. He receives research support from Pfizer. He receives royalties from UpToDate.

PY - 2020/4/2

Y1 - 2020/4/2

UR - http://www.scopus.com/inward/record.url?scp=85062358401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062358401&partnerID=8YFLogxK

U2 - 10.1080/09273948.2019.1569245

DO - 10.1080/09273948.2019.1569245

M3 - Letter

C2 - 30811269

AN - SCOPUS:85062358401

VL - 28

SP - 491

EP - 493

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 3

ER -